ARTERIUS PRESS RELEASE

Date: April 2023

Arterius Limited, a Leeds UK-based company developing innovative medical devices with a focus on next generation bioresorbable peripheral stents and drug coated balloons, has announced that it has appointed Gerard Harper as Chief Financial Officer. In this role, Gerard will help Arterius to develop and drive the commercial strategy for the successful launch of a suite of innovative technologies in its current pipeline.

Gerard brings extensive experience in medical devices and healthcare companies gained through roles in investment banking, venture capital and early-stage companies. Gerard held finance and commercial roles at Quanta Dialysis Technologies for over six years helping to guide its development into one of the most prominent emerging medical device companies in the UK.

Gerard will build on the success of Kadem Al-Lamee, co-founder and Chief Technical Officer who is leading the development of the existing product pipeline and IP and of new applications and technologies.

Chris Meredith, Chairman of Arterius, commented:

“I want to welcome Gerard to Arterius as he brings a wealth of leadership experience in commercial development and investment in life sciences. His track record will be invaluable as Arterius continues its journey through the development of innovative technologies in the MedTech sector.”

Gerard Harper commented:

“I am delighted to join Arterius at this exciting time as it aims to bring two class-leading product platforms to market, with the capability to transform the management of peripheral arterial disease”.

END

To learn more visit: www.arterius.co.uk